Author Archives: Karin Lillis

Scientists find urine test could offer a non-invasive approach for diagnosis of IBS

Scientists at McMaster University have identified new biomarkers for irritable bowel syndrome (IBS) in urine, which could lead to better treatments and reduce the need for costly and invasive colonoscopy procedures currently used for diagnosis. Little is known about the causes of IBS, a chronic and often debilitating gastrointestinal disorder which affects hundreds of thousands of Canadians in which diagnosis ...

Read More »

FDA halts fecal microbiota transplant after patient death

The U.S. Food and Drug Administration has issued a safety communication regarding the use of Fecal Microbiota for Transplantation (FMT) and the risk of serious or life-threatening infections due to transmission of multi-drug resistant organisms (MDROs), as well as protections FDA has determined are needed for patients receiving investigational FMT. Two immunocompromised adults who received investigational FMT developed invasive bacterial infections due ...

Read More »

Many patients with pancreatic cancer miss out on treatment that may extend survival

Despite potential for prolonging survival with treatment, one-third of patients with metastatic pancreatic cancer do not see a medical oncologist, and even more do not receive cancer-directed treatment, found new research published in CMAJ (Canadian Medical Association Journal). Pancreatic cancer has a high death rate and is often diagnosed in advanced stages. “The data suggest that there are many missed opportunities for important ...

Read More »

New compound that kills antibiotic-resistant superbugs discovered

A new compound which visualizes and kills antibiotic resistant superbugs has been discovered by scientists at the University of Sheffield and Rutherford Appleton Laboratory (RAL). The team, led by Professor Jim Thomas, from the University of Sheffield’s Department of Chemistry, is testing new compounds developed by his PhD student Kirsty Smitten on antibiotic resistant gram-negative bacteria, including pathogenic E. coli. Gram-negative ...

Read More »

Fujifilm offerings at Digestive Disease Week 2019

Fujifilm will showcase its portfolio of endoscopic imaging, minimally invasive surgical endoscopy, enterprise imaging, and hepatology surveillance solutions at Digestive Disease Week (DDW) 2019 from May 19-21 at the San Diego Convention Center in San Diego, California. Fujifilm products will also be included in more than a dozen educational and training opportunities during the conference. In booth No. 4823 at DDW 2019, Fujifilm will showcase the following endoscope solutions for ...

Read More »